Skip to main content
Premium Trial:

Request an Annual Quote

Partek, Gulf Scientific, Greiner Bio-One, Invitrogen, OGT, Ocean Ridge Biosciences

Partek Signs up Gulf Scientific as Middle East Distributor
Partek said this week that Gulf Scientific, a life science technology supplier based in the United Arab Emirates, will supply customers throughout the Persian Gulf region with its software solutions.
Under the agreement, Gulf Scientific will market, distribute, and support Partek’s Genomics Suite, Discovery Suite, QSAR Solution, and Screener Solution in Saudi Arabia, Egypt, Kuwait, Qatar, Yemen, Oman, Bahrain, Iraq, Jordan, Lebanon, and the United Arab Emirates, Partek said.
Partek’s software packages include statistical analysis and interactive data visualization tools.
Financial terms of the agreement were not released.

Greiner Bio-One Licenses Invitrogen's PCR Sample-Prep Tech for HPV Test
Greiner Bio-One has licensed Invitrogen’s deoxyuridine triphosphate technology for use in a PCR-based HPV test and in DNA array products, the companies said last week.
Greiner Bio-One said it will use dUTP in place of deoxythymidine triphosphate to prevent false positives during PCR by reducing sample contamination.
The company said the use of dUTP will improve the reliability of its PapilloCheck HPV test and its DNA-array CytoCheck products. Greiner Bio-One will begin offering product kits for PapilloCheck with dUTP this month, and plans to offer dUTP-based kits for CytoCheck this fall.
Financial terms of the agreement were not released.

OGT Grants License to Ocean Ridge Biosciences
Oxford Gene Technology and Ocean Ridge Biosciences have completed a licence agreement granting ORB access to an OGT patent that will enable ORB to offer DNA expression and microRNA profiling services worldwide from its headquarters in Jupiter, Fla.
ORB Senior Scientist David Willoughby said the license will allow the firm to provide its services to the “general research community,” both locally in Florida and throughout the US and Canada, and will enable ORB to ”continue with our mission of improving human health through the provision of accurate, affordable, and information-rich genomic services.”
The licence will remain valid for the patents’ lifetime, OGT said.
Financial details were not disclosed.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.